Table 3. Multivariable analysis for predicting the duration of postoperative urinary incontinence (≥ 3 vs. 0–3 months).

Variables	Odds ratio (95% CI)	P value
Age (≥ 75 vs. 65–69yr)	2.35 (1.17–4.71)	0.016
Preoperative PSA concentration (≥ 10 vs. < 10 ng/mL)	0.82 (0.41–1.66)	0.585
Preoperative ECOG grade (≥ 1 vs. 0)	7.01 (2.85–17.26)	< 0.001
Underlying disease (present vs. absent)
Diabetes mellitus	1.73 (0.71–4.21)	0.227
Hypertension	1.07 (0.59–1.97)	0.818
Hyperlipidemia	1.38 (0.36–5.28)	0.643
Coronary artery disease	2.00 (0.37–10.91)	0.424
Neoadjuvant hormonal therapy (present vs. absent)	3.18 (not calculated)	0.999
Pathological stage (T3–4 vs. T2)	1.59 (0.78–3.22)	0.200
RP Gleason score (≥ 8 vs. ≤7)	1.04 (0.37–2.94)	0.942
Erectile dysfunction (present vs. absent)	1.95 (1.06–3.56)	0.031

CI, confidence interval; PSA, prostate-specific antigen; ECOG, Eastern Cooperative Oncology Group; RP, radical prostatectomy.